Clover Health Investments (CLOV) Reports Q2 results; offers guidance

Clover Health Investments (NASDAQ: CLOV) reported Q2 Revenue for the quarter at $477.62 million versus the consensus estimate of $468.3 million.

GUIDANCE:

Clover Health Investments sees FY2025 revenue of $1.8-1.875 billion, versus the consensus of $1.863 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Baker Hughes wins long-term service deal for Nigeria gas plant
• Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand